- Home
- MOV vs HUMA Comparison
MOV vs HUMA Comparison
Compare MOV & HUMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MOV
- HUMA
- Stock Information
- Founded
- MOV 1961
- HUMA 2004
- Country
- MOV United States
- HUMA United States
- Employees
- MOV N/A
- HUMA N/A
- Industry
- MOV Consumer Specialties
- HUMA Biotechnology: Pharmaceutical Preparations
- Sector
- MOV Consumer Discretionary
- HUMA Health Care
- Exchange
- MOV Nasdaq
- HUMA Nasdaq
- Market Cap
- MOV 339.1M
- HUMA 250.2M
- IPO Year
- MOV 1993
- HUMA N/A
- Fundamental
- Price
- MOV $18.27
- HUMA $1.51
- Analyst Decision
- MOV Strong Buy
- HUMA Strong Buy
- Analyst Count
- MOV 1
- HUMA 8
- Target Price
- MOV $31.50
- HUMA $10.88
- AVG Volume (30 Days)
- MOV 145.4K
- HUMA 5.9M
- Earning Date
- MOV 08-28-2025
- HUMA 08-11-2025
- Dividend Yield
- MOV 7.66%
- HUMA N/A
- EPS Growth
- MOV N/A
- HUMA N/A
- EPS
- MOV 0.77
- HUMA N/A
- Revenue
- MOV $655,597,000.00
- HUMA $818,000.00
- Revenue This Year
- MOV $0.71
- HUMA N/A
- Revenue Next Year
- MOV N/A
- HUMA $949.92
- P/E Ratio
- MOV $23.68
- HUMA N/A
- Revenue Growth
- MOV 0.79
- HUMA N/A
- 52 Week Low
- MOV $12.85
- HUMA $1.15
- 52 Week High
- MOV $24.47
- HUMA $6.77
- Technical
- Relative Strength Index (RSI)
- MOV 70.66
- HUMA 36.87
- Support Level
- MOV $16.75
- HUMA $1.43
- Resistance Level
- MOV $17.55
- HUMA $1.67
- Average True Range (ATR)
- MOV 0.49
- HUMA 0.15
- MACD
- MOV 0.20
- HUMA -0.01
- Stochastic Oscillator
- MOV 99.42
- HUMA 23.32
About MOV Movado Group Inc.
Movado Group Inc designs, develops, sources, markets, and distributes fine watches in the United States and internationally. It operates through the Watch and Accessory Brands and Company Stores segment. The Watch and Accessory Brands segment includes the designing, manufacturing, and distribution of watches and, to a lesser extent, jewelry and other accessories of quality owned brands and licensed brands. Its Company Stores segment includes the company's retail outlet locations in the United States and Canada. It generates maximum revenue from the Watch and Accessory Brands segment. Geographically, it derives the majority of its revenue from its international locations.
About HUMA Humacyte Inc.
Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.